Podimetrics, an organization that is helping sufferers with diabetes save you severe headaches, is teaming up with HealthMed, an worker fitness and wellness platform.
HealthMed objectives to combine Podimetrics’ SmartMat era into its portfolio of advantages supposed for massive employers, hospitals and municipalities. The corporate additionally supplies worker wellness and psychological fitness systems.
Podimetrics’ SmartMat measures the foot temperature of high-risk sufferers and scans for early indicators of irritation that might result in wounds, amputations and diabetic foot ulcers.
“Our partnership with HealthMed is a sturdy collaboration, and we’re excited to paintings in combination to beef up folks with complicated diabetes who’re on the biggest menace for severe headaches,” Dr. Jon Bloom, CEO of Podimetrics, mentioned in a commentary.
“We percentage a commonplace undertaking to concentrate on prevention and enhance fitness results. This collaboration is aimed toward attaining that purpose in combination.”
Tracy Webster, founding father of HealthMed, mentioned the partnership with Podimetrics and its cutting edge resolution for managing sophisticated diabetes will receive advantages self-insured employers and enhance the continuum of care.
“We stay up for the sure affect we will make on fitness results and the whole price of care,” Webster mentioned in a commentary.
THE LARGER TREND
In March, Podimetrics partnered with receive advantages control group Alivi Well being, which integrated SmartMat era into its portfolio of uniqueness advantages to reinforce its podiatry advantages for fitness plans and payers.
In 2024, Podimetrics sued Eire-based Bluedrop Scientific for patent infringement. Bluedrop has a tool that permits an individual with diabetes to scan their ft for possible cases of foot ulcers.
In step with the compliant, Bluedrop allegedly “without delay and/or thru subsidiaries, workers, intermediaries or industry names” dedicated acts of infringement by way of “uploading, providing to promote and promoting an instrumentality that infringes [Podimetrics’] Patents-in-Go well with.” The case was once disregarded after Podmetrics withdrew its declare.
In 2022, Podimetrics scored $45 million in a Collection C financing spherical. The capital was once used to make bigger Podimetrics’ product construction and analysis groups in addition to build up the selection of services and products supplied by way of its nurse beef up groups.
In 2019, Podimetrics raised $13.4 million in Collection B investment. Rock Well being, Norwich Ventures and Clinical Well being Building participated within the spherical.
Different firms within the diabetes area come with Dexcom, which in 2024 made a $75 million strategic funding in health-tracking ring maker Oura and established a strategic partnership to permit two-way knowledge waft between Dexcom’s steady glucose observe (CGM) and the Oura Ring. Dexcom’s $75 million funding introduced Oura’s valuation to greater than $5 billion.
Diabetes and insulin control instrument corporate Glytec and pharmaceutical company Roche joined forces closing 12 months to permit using Glytec’s instrument in reference to Roche’s point-of-care smart-device health facility blood glucose device cobas pulse within the U.S. and international markets.
In step with Roche, cobas pulse’s strip structure supplies lab-like effects and lowers the wish to repeat exams. The device can be utilized on all affected person populations, together with neonates and in depth care sufferers.
